You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:


Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022006

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 022006 describes SABRIL, which is a drug marketed by Lundbeck Pharms Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the SABRIL profile page.

The generic ingredient in SABRIL is vigabatrin. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the vigabatrin profile page.
Summary for 022006
Applicant:Lundbeck Pharms Llc
Formulation / Manufacturing:see details
Pharmacology for NDA: 022006
Medical Subject Heading (MeSH) Categories for 022006
Suppliers and Packaging for NDA: 022006
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SABRIL vigabatrin FOR SOLUTION;ORAL 022006 NDA Lundbeck Pharmaceuticals LLC 67386-211 67386-211-65 50 PACKET in 1 CARTON (67386-211-65) > 10 mL in 1 PACKET

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength500MG/PACKET
Approval Date:Aug 21, 2009TE:AARLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.